Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC)

Zhu, Xueru; Wang, Yiwei; Li, Hongjia; Xue, Wenji; Wang, Ruifen; Wang, Lifeng; Zhu, Meiling; Zheng, Leizhen

doi:10.7150/jca.18487



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2017; 8(8):1477-1483. doi:10.7150/jca.18487 This issue Cite

Research Paper

Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC)

Xueru Zhu¹, Yiwei Wang¹, Hongjia Li², Wenji Xue¹, Ruifen Wang³, Lifeng Wang³, Meiling Zhu^1✉, Leizhen Zheng^1✉

1. Department of Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, Shanghai, China;
2. Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200092, Shanghai, China;
3. Department of Pathology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, Shanghai, China.

Citation:

Zhu X, Wang Y, Li H, Xue W, Wang R, Wang L, Zhu M, Zheng L. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC). J Cancer 2017; 8(8):1477-1483. doi:10.7150/jca.18487. https://www.jcancer.org/v08p1477.htm

Other styles

Abstract

Purpose: The aim of the study was to investigate the effect of deficiency of hMLH1 and hMSH2 expression on the prognosis of early gastric cancer (EGC) in Chinese populations.

Methods: A total of 160 EGC patients who underwent curative gastrectomy with lymphadenectomy from January 2011 to July 2014 at Xinhua Hospital were evaluated. The expression rates of hMLH1 and hMSH2 were examined using tissues preserved in paraffin blocks by immunohistochemical staining. The clinicopathological characteristics and prognosis of EGC with deficient hMLH1 and hMSH2 were analyzed.

Results: On immunohistochemical staining, the loss expression of hMLH1 and hMSH2 were observed in 89 (55.6%) and 45 (28.1%), respectively. The hMLH1 deficiency was associated with the middle third of tumor location (P = 0.041). According to Kaplan-Meier survival analysis and Log-Rank test, the loss expression of hMLH1 and hMSH2 were associated with worse survival than positive hMLH1 (HR = 0.247, 95% CI = 0.078-0.781, P = 0.017) and hMSH2 (HR = 0.174, 95% CI = 0.051-0.601, P = 0.006) in EGC.

Conclusion: The main conclusions were as follows: The hMLH1 deficiency was preferred to the middle third of EGC. Lymph node metastasis (LNM) was a prognostic factor of EGC. And the prognosis of EGC patients with deficient mismatch repair (dMMR, mainly including deficient hMLH1 and hMSH2) was obviously worse than proficient mismatch repair (pMMR).

Keywords: early gastric cancer, hMLH1, hMSH2, prognosis.

Citation styles

APA

Zhu, X., Wang, Y., Li, H., Xue, W., Wang, R., Wang, L., Zhu, M., Zheng, L. (2017). Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC). Journal of Cancer, 8(8), 1477-1483. https://doi.org/10.7150/jca.18487.

ACS

Zhu, X.; Wang, Y.; Li, H.; Xue, W.; Wang, R.; Wang, L.; Zhu, M.; Zheng, L. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC). J. Cancer 2017, 8 (8), 1477-1483. DOI: 10.7150/jca.18487.

NLM

CSE

Zhu X, Wang Y, Li H, Xue W, Wang R, Wang L, Zhu M, Zheng L. 2017. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC). J Cancer. 8(8):1477-1483.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.